News – Page 345 – Endpoints News

Priority review for Takeda’s ultra-rare blood clot ERT; FDA to give another look at Ardelyx’s CKD drug

3 years ago

Ex-FDA neuro chief Billy Dunn is taking a spin through the revolving door with biopharma — and that's a problem

3 years ago

SPAC for 2025 BLA: Non-viral gene therapy biotech enGene, steered by ex-Mythic leaders, finds Forbion blank check

3 years ago

AstraZeneca pushes Tagrisso-chemo combo following positive progression-free survival data

3 years ago

Roche touts PhII win for BTK inhibitor in multiple sclerosis as PhIII showdown with Sanofi, Merck KGaA, Novartis ...

3 years ago

Gilead woos Cindy Perettie from Roche to lead Kite after Christi Shaw departs

3 years ago

The FTC just went after 'bundling' in Amgen's $28B deal. Will it put a chill on future M&A?

3 years ago

FDA approves Allergan's newest hyaluronic acid injectable — with a new delivery system

3 years ago

Podcast ad spending rises among pharma companies, as the audio channel booms across industries

3 years ago

Post-recall, OTC eye drop maker handed a warning letter from the FDA

3 years ago

Ipca Laboratories cited for quality issues at India facility that produces API

3 years ago

FDA signals support for Pfizer’s RSV shot in adcomm docs before crucial vote

3 years ago

MarketingRx roundup: Pharma ad boost on YouTube; Merck re-ups lung cancer test social advocacy

3 years ago

Diabetes and obesity experts on social media call emerging class of drugs ‘game changers’ — Harris Poll

3 years ago

AstraZeneca is leaving the lobbying group PhRMA, third drugmaker to ditch trade group in last five months

3 years ago

Viking claims NASH win after meeting primary endpoint in PhIIb study

3 years ago

BioXcel touts healthy volunteer data for neuro therapy; Ionis, Chinook partner on rare kidney disease

3 years ago

#trekfortomorrow #3: How to survive the rigors of the Pacific Crest Trail and a career in cancer research

3 years ago

Bayer launches 'Seeing Red' campaign to raise awareness for Mirena's use in heavy periods

3 years ago

Lilly’s Prevail taps Jennifer Doudna's spinout Scribe Therapeutics for neuro genetic medicines

3 years ago

On a personal mission for his daughter, Paul Bresge launches another eye disease biotech with $100M for Ray ...

3 years ago

$97M gene therapy consortium aims to give companies and rare disease families a ‘north star’

3 years ago

Peter Hecht has a new syndicate, $81M in backing and a fresh shot at glory as his last start-up sputters out

3 years ago

Astellas, Sony partner up for antibody-drug conjugate platform to create 'better performing' drugs

3 years ago

First page Previous page 342 343 344345346 347 348 Next page Last page